Top

Published in:

Open Access 01-12-2018 | Case Report

Rhabdomyolysis secondary to systemic lupus erythematosus

Authors: Daniel Nguyen, Farah Alsaati, Jena Deitrick, Kamel Azhar, Evelyn Sbar

Published in: Autoimmunity Highlights | Issue 1/2018

Abstract

Systemic lupus erythematous (SLE) is a systemic auto-immune disorder with a variety of presentations and wide spread organ involvement. We present a case report of a patient with an SLE exacerbation as well as concurrent rhabdomyolysis with massively elevated CPK (304,700 U/L). Though a rarely reported effect of SLE, rhabdomyolysis can be severe and potentially lethal secondary or concurrent to an acute SLE episode. This case report demonstrates the association between SLE and rhabdomyolysis, which is not well described in the current literature.

Oshima Y (2011) Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med (Tokyo, Jpn) 50(8):845–853CrossRef

Huerta-Alardín AL, Varon J, Marik PE (2005) Bench-to-bedside review: rhabdomyolysis—an overview for clinicians. Crit Care (Lond, Engl) 9(2):158–169. https://doi.org/10.1186/cc2978 CrossRef

Blanco JR, Zabalza M, Salcedo J, Echeverria L, García A, Vallejo M (2002) Rhabdomyolysis of infectious and noninfectious causes. South Med J 95(5):542–544CrossRef

Pesik NT, Otten EJ (1996) Severe rhabdomyolysis following a viral illness: a case report and review of the literature. J Emerg Med 14(4):425–428CrossRef

Wang LM, Tsai ST, Ho LT, Hu SC, Lee CH (1994) Rhabdomyolysis in diabetic emergencies. Diabetes Res Clin Pract 26(3):209–214CrossRef

Bennett WR, Huston DP (1984) Rhabdomyolysis in thyroid storm. Am J Med 77(4):733–735CrossRef

García-Reynoso MJ, Veramendi-Espinoza LE, Ruiz-Garcia HJ (2014) Paresia ascendente como comienzo de inusual asociación entre miopatía autoinmune necrosante y lupus eritematoso sistémico. Reumatología Clínica 10(3):183–186. https://doi.org/10.1016/j.reuma.2013.03.006 CrossRefPubMed

de Carvalho JF, da Mota LMH, Bonfa E (2011) Fatal rhabdomyolysis in systemic lupus erythematosus. Rheumatol Int 31(9):1243–1245. https://doi.org/10.1007/s00296-010-1674-0 CrossRefPubMed

Cherif E, Ben Hassine L, Kechaou I, Khalfallah N (2013) Hypokalemic rhabdomyolysis: an unusual presentation of Sjogren’s syndrome. BMJ Case Rep. https://doi.org/10.1136/bcr-2013-201345 CrossRefPubMedPubMedCentral

10.

Khan UF, Tsu LC, Tan K-B, Huang J, Wong AL (2017) Hypokalaemia in Sjögren’s syndrome: the missing piece. Clin Med 17(1):40–42. https://doi.org/10.7861/clinmedicine.17-1-40 CrossRef

11.

Prakash EBS, Fernando ME, Sathiyasekaran M, Bhoopathy RM, Jayanth JJ, Samuel J (2006) Primary Sjö-gren’s syndrome presenting with distal, renal tubular acidosis and rhabdomyolysis. J Assoc Phys India 54:949–950

Title: Rhabdomyolysis secondary to systemic lupus erythematosus
Authors: Daniel Nguyen
Farah Alsaati
Jena Deitrick
Kamel Azhar
Evelyn Sbar
Publication date: 01-12-2018
Publisher: Springer International Publishing
Published in: Autoimmunity Highlights / Issue 1/2018
Print ISSN: 2038-0305
Electronic ISSN: 2038-3274
DOI: https://doi.org/10.1007/s13317-018-0105-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Rhabdomyolysis secondary to systemic lupus erythematosus

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Performance analysis of automated evaluation of antinuclear antibody indirect immunofluorescent tests in a routine setting

Remission of aggressive autoimmune disease (dermatomyositis) with removal of infective jaw pathology and ozone therapy: review and case report

Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome

Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page